Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 80 years old
- People who have been diagnosed with primary open angle glaucoma or normal tension glaucoma affecting both eyes
- People whose glaucoma has caused a measurable loss in their side or peripheral vision in at least one eye, as confirmed by a specific vision field test
- People whose central (straight-ahead) vision is still reasonably well preserved, as measured by a standard eye test
- People whose vision and vision loss have been stable for at least 3 months
- People who score 22 or above on a standard memory and thinking assessment (the Hong Kong version of the Montreal Cognitive Assessment)
Who may not be able to join:
- People who have other eye conditions besides glaucoma (such as age-related macular degeneration, diabetic eye disease, or moderate to severe cataracts), or who have severe hearing difficulties
- People with serious medical conditions such as stroke or Parkinson's disease, or who have a history of neurological conditions (such as brain surgery or a brain tumour), or who have been diagnosed with dementia or another cognitive impairment
- People who have problems with balance or coordination related to the inner ear or cerebellum, or who have a history of vertigo
- People who are currently taking medications for neurological or psychiatric conditions (such as sedatives or sleeping tablets) that could affect movement or motor control
- People for whom non-invasive brain stimulation (a technique used in this trial) would be considered medically unsuitable (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Allen Cheong, PhD, The Hong Kong Polytechnic University
Phone: 852-27666108
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
High-resolution perimetry (HRP)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.